Synonym
MK-0736; MK 0736; MK0736.
IUPAC/Chemical Name
3-(4-(3-(ethylsulfonyl)propyl)bicyclo[2.2.2]octan-1-yl)-4-methyl-5-(2-(trifluoromethyl)phenyl)-4H-1,2,4-triazole
InChi Key
ORQZQBUNAMJFCY-UHFFFAOYSA-N
InChi Code
InChI=1S/C23H30F3N3O2S/c1-3-32(30,31)16-6-9-21-10-13-22(14-11-21,15-12-21)20-28-27-19(29(20)2)17-7-4-5-8-18(17)23(24,25)26/h4-5,7-8H,3,6,9-16H2,1-2H3
SMILES Code
CCS(CCCC1(CC2)CCC2(C3=NN=C(C4=CC=CC=C4C(F)(F)F)N3C)CC1)(=O)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Related CAS#
719272-79-4 (MK-0736 free base)
719274-77-8 (MK-0736 hydrochloride)
Preparing Stock Solutions
The following data is based on the
product
molecular weight
469.57
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Anagnostis P, Katsiki N, Adamidou F, Athyros VG, Karagiannis A, Kita M,
Mikhailidis DP. 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel
agents for the treatment of metabolic syndrome and obesity-related disorders?
Metabolism. 2013 Jan;62(1):21-33. doi: 10.1016/j.metabol.2012.05.002. Review.
PubMed PMID: 22652056.
2: Shah S, Hermanowski-Vosatka A, Gibson K, Ruck RA, Jia G, Zhang J, Hwang PM,
Ryan NW, Langdon RB, Feig PU. Efficacy and safety of the selective 11β-HSD-1
inhibitors MK-0736 and MK-0916 in overweight and obese patients with
hypertension. J Am Soc Hypertens. 2011 May-Jun;5(3):166-76. doi:
10.1016/j.jash.2011.01.009. PubMed PMID: 21419745.
3: Veryard C. American Society for Clinical Pharmacology and Therapeutics
(ASCPT)-111th annual meeting. 17-20 March 2010, Atlanta, GA, USA. IDrugs. 2010
May;13(5):286-8. PubMed PMID: 20432179.